Healthcare Sales & Marketing Network News: osteoporosis

Searching News Database: osteoporosis

HSMN NewsFeed - 1 Mar 2024
Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar(R) Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect(TM) Injector
Devices Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 18 Aug 2023
FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy
Biopharmaceuticals FDA

HSMN NewsFeed - 29 May 2023
Abiogen Pharma Completes the Acquisition of Effrx
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 6 Jan 2023
Aeglea BioTherapeutics Announces Update to Corporate Structure to Increase Operational Efficiency
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Nov 2022
Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Oct 2022
FDA Approves First IND of its Kind for Allogenic Exosomal Treatment of Female Reproductive Disorder - Primary Ovarian Insufficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Aug 2022
Aeglea BioTherapeutics Announces Leadership Transition and Corporate Restructuring
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jan 2022
SetBone Medical Announces $1.6 Million Financing
Devices Orthopaedic Venture Capital

HSMN NewsFeed - 9 Dec 2021
Richter and Hikma sign exclusive commercialisation and license agreement for denosumab in the US, a proposed biosimilar referencing Prolia(R) and Xgeva(R)
Biopharmaceuticals Generics Licensing

HSMN NewsFeed - 25 Nov 2020
Echolight Announces New Executive Hires
Devices Personnel

HSMN NewsFeed - 19 Oct 2020
Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partners
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Aug 2020
DiscGenics Raises $50 Million in Series C Funding
Regenerative Medicine Orthopaedic Venture Capital

HSMN NewsFeed - 19 May 2020
AllianceRx Walgreens Prime One of Only Two Specialty Pharmacies to Distribute Vyepti(TM), the First and Only Intravenous Preventive Treatment for Migraine
Biopharmaceuticals Distribution

HSMN NewsFeed - 31 Mar 2020
Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Jan 2020
Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 12 Dec 2019
European Commission Approves EVENITY(R) (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 Oct 2019
SmartPharm Therapeutics Appoints John T. Potts, MD, DSc, to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Oct 2019
EVENITY(R) (Romosozumab) Receives Positive CHMP Opinion For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Oct 2019
Upsher-Smith Laboratories Launches Tosymra(TM) (sumatriptan) Nasal Spray For The Acute Treatment Of Migraine In Adults
Biopharmaceuticals Neurology Drug Delivery Product Launch

HSMN NewsFeed - 20 Aug 2019
Richter Launched Terrosa(R), its Biosimilar Teriparatide Across Europe
Biopharmaceuticals Product Launch

HSMN NewsFeed - 28 Jun 2019
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 Jun 2019
Smith & Nephew Launches the CONQUEST FN(TM) Femoral Neck Fracture System, a Fresh Approach to Hip Preservation Versus Current Treatment Options
Devices Orthopaedic Product Launch

HSMN NewsFeed - 8 Jan 2019
EVENITY(TM) (romosozumab) Receives Approval In Japan For The Treatment Of Osteoporosis In Patients At High Risk Of Fracture
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 Aug 2018
Bone Index Ltd. Announces Medicare Reimbursement Coverage for Bindex Osteoporosis Measurement
Diagnostics Reimbursement

HSMN NewsFeed - 24 Jul 2018
AbbVie Receives U.S. FDA Approval of ORILISSA(TM) (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
Biopharmaceuticals FDA Product Launch

HSMN NewsFeed - 13 Jul 2018
Amgen And UCB Resubmit Biologics License Application (BLA) For EVENITY(TM) (romosozumab) To The US FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Jun 2018
Medtronic Announces Second Bone Cement Solution Indicated for Treating Sacral Fractures
Devices Interventional Radiology Orthopaedic FDA

HSMN NewsFeed - 18 Jun 2018
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Biopharmaceuticals

HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 27 Apr 2018
Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia(R) (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 Apr 2018
Apitope Announces Positive Results with Novel Treatment for Graves' Disease
Biopharmaceuticals

HSMN NewsFeed - 23 Feb 2018
Amgen Receives Positive Opinion Expanding Use Of XGEVA(R) (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 7 Feb 2018
UNITY Biotechnology Adds Accomplished R&D Leader David L. Lacey, M.D., to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Sep 2017
Janssen Receives CHMP Positive Opinion for Guselkumab Recommending Approval for the Treatment of Moderate to Severe Plaque Psoriasis in the European Union
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 17 Jul 2017
Amgen And UCB Provide Update On Regulatory Status Of EVENITY(TM) (romosozumab) In The US
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Jul 2017
Viking Therapeutics Completes Enrollment in Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture
Biopharmaceuticals Orthopaedic

HSMN NewsFeed - 22 May 2017
Amgen And UCB Announce Top-Line Phase 3 Data From Active-Comparator Study Of EVENITY(TM) (Romosozumab) In Postmenopausal Women With Osteoporosis
Biopharmaceuticals

HSMN NewsFeed - 15 May 2017
Alcobra Announces Leadership Update
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Apr 2017
FDA Approves Radius Health’s TYMLOS(TM) (abaloparatide), a Bone Building Agent for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Mar 2017
Motus GI Appoints Samuel R. Nussbaum, M.D., to Board of Directors
Devices Gastroenterology Oncology Personnel

HSMN NewsFeed - 10 Feb 2017
FDA Approves EMFLAZA(TM) (deflazacort) Tablets and Oral Suspension for the Treatment of Duchenne Muscular Dystrophy in Patients 5 Years and Older
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Feb 2017
Glide Technologies Announces Successful £3.2 Million ($4.0 Million) Fundraising
Devices Biopharmaceuticals Drug Delivery Venture Capital

HSMN NewsFeed - 13 Jan 2017
Osseon Receives New Patent
Devices Orthopaedic

HSMN NewsFeed - 14 Nov 2016
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 27 Oct 2016
BONESUPPORT(TM) Raises $37 Million (SEK 327 million) to Drive Product Sales and Deliver Further Value From CERAMENT(TM) Injectable Drug Eluting Bioceramic Platform
Devices Orthopaedic Venture Capital

HSMN NewsFeed - 2 Sep 2016
Merck Provides Update on Odanacatib Development Program
Biopharmaceuticals

HSMN NewsFeed - 22 Jul 2016
Amgen and UCB Submit Biologics License Application for Romosozumab to the FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 11 May 2016
Hologic Introduces the MyoSure(R) REACH Device to Help Physicians Access the Hard-to-Reach Upper Third of the Uterine Cavity
Devices Product Launch

HSMN NewsFeed - 21 Mar 2016
Amgen And UCB Announce Positive Top-Line Results From Phase 3 Study Evaluating Romosozumab In Men With Osteoporosis
Biopharmaceuticals

HSMN NewsFeed - 22 Feb 2016
Amgen And UCB Announce Positive Top-Line Results From The Phase 3 Study Of Romosozumab In Postmenopausal Women With Osteoporosis
Biopharmaceuticals

HSMN NewsFeed - 14 Sep 2015
POZEN Appoints James P. Tursi, M.D. Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Aug 2015
Radius Health Announced That it Has Appointed Catherine Friedman to the Board of Directors
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 10 Aug 2015
Chiasma Expands Management Team with Announcement of Anand Varadan as Chief Commercial Officer
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Apr 2015
Radius Health Today Announced That it Has Appointed Brent Hatzis-Schoch as Senior Vice President and General Counsel
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Apr 2015
Corium Announces Appointment of Eric H. Bjerkholt to Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 18 Mar 2015
Innocoll AG Appoints James Tursi, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Feb 2015
ZS Pharma Hires Key Medical Affairs and Commercial Executives
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Oct 2014
VEXIM to Initiate Clinical Study to Support Planned 510(k) Application to Market SpineJack(R) in the United States
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 6 Oct 2014
Zavation Launches ZVPlasty(TM) for the treatment of Spinal Fractures
Devices Orthopaedic Neurosurgery Product Launch

HSMN NewsFeed - 5 Sep 2014
Mylan Launches Generic Boniva(R) Injection
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 27 Aug 2014
Ligand Partner GlaxoSmithKline Receives U.S. FDA Approval for Promacta(R)/Revolade(TM) For Use in Patients with Severe Aplastic Anemia
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Aug 2014
Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals
Biopharmaceuticals Licensing

HSMN NewsFeed - 13 Aug 2014
Tarsa Therapeutics Secures $10 Million And Adds Industry Veteran Daniel Soland As A Director
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 29 Jul 2014
Abide Therapeutics Appoints Nancy Thornberry to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jul 2014
MicroCHIPS, Inc. appoints Cheryl R. Blanchard, Ph.D., as Chief Executive Officer
Devices Drug Delivery Personnel

HSMN NewsFeed - 18 Jun 2014
Benvenue Medical Secures $64 Million Financing
Devices Orthopaedic Neurosurgery Venture Capital

HSMN NewsFeed - 13 Jun 2014
Ligand Partner GSK Announces Results of Phase 3 PETIT2 Study of Eltrombopag (Promacta(TM)/Revolade(TM)) in Pediatric Patients with Chronic Immune Thrombocytopenia
Biopharmaceuticals

HSMN NewsFeed - 19 May 2014
Genkyotex Announces New Senior Management and Board Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jan 2014
Kiva(R) VCF Treatment System Receives FDA Clearance For Vertebral Compression Fractures
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 13 Jan 2014
Alcobra Strengthens Management Team With Addition of Industry Veteran David C. Baker as Chief Commercial Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 17 Dec 2013
Azure Biotech Announces Hiring of Ralph Makar as CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Dec 2013
Momenta Pharmaceuticals Appoints Michael Franken, M.D. as President, Biosimilars Business
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Dec 2013
TherapeuticsMD Appoints Joel S. Krasnow, M.D. as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Nov 2013
AmpliPhi Biosciences Announces the Appointment of Baxter Phillips, III, as Vice President of Corporate Strategy and Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Nov 2013
Smith & Nephew Introduces Advanced Biocomposite Material for Use in Arthroscopic Surgery
Devices Orthopaedic Product Launch

HSMN NewsFeed - 3 Oct 2013
Pfizer Inc. Announces FDA Approval of DUAVEE(TM) (conjugated estrogens/ bazedoxifene) for the Treatment of Moderate-to-Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause and the Prevention of Postmenopausal Osteoporosis [1]
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Aug 2013
Hologic Launches New Bone Densitometer Platform for Osteoporosis, Cardiovascular Disease, and Obesity Assessment
Devices Radiology Product Launch

HSMN NewsFeed - 26 Jul 2013
Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 10 May 2013
Novartis drug Ilaris(R) approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis
Biopharmaceuticals. FDA

HSMN NewsFeed - 1 May 2013
William L. Ashton Joins Galena Biopharma's Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 26 Apr 2013
Sectra Signs Distribution Agreement in Puerto Rico
Devices Radiology Distribution

HSMN NewsFeed - 16 Apr 2013
Osseon(R) announces Balloon Osseoplasty Case in Lima, Ohio
Devices Interventional Orthopaedic Neurosurgery

HSMN NewsFeed - 7 Mar 2013
Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Feb 2013
Independent Study Demonstrates Clinical Advantages Of Kiva(R) Over Balloon Kyphoplasty
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 14 Feb 2013
Santarus Announces Commercial Launch of UCERIS (budesonide) Extended Release Tablets
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 7 Feb 2013
Amgen Outlines Long-Term Strategy
Biopharmaceuticals

HSMN NewsFeed - 3 Jan 2013
Alphatec Spine Receives U.S. FDA 510(K) Market Clearance for Two New Products and Receives Japanese Shonin Approval to Begin Marketing Its Novel(R) Peek Lumbar Spinal Spacers
Devices Neurosurgery Orthopaedic FDA

HSMN NewsFeed - 23 Oct 2012
Bovie Medical Corporation to Conduct Conference Call on J-Plasma(TM) Technology
Devices Surgery

HSMN NewsFeed - 28 Sep 2012
EffRx Names Lorenzo Bosisio Vice President, Head of Business Development and Marketing
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 27 Sep 2012
Alphatec Spine Receives Board Approval to Acquire Assets of Spine Implant Business
Devices Orthopaedic Neurosurgery Acquisitions

HSMN NewsFeed - 18 Sep 2012
Alphatec Spine Releases Alphatec NEXoss(TM) Nanostructure Bio-Active Matrix and Announces the First Patient Implant
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 5 Sep 2012
Alvine Pharmaceuticals’ ALV003 Receives Fast Track Designation From the FDA for the Potential Treatment of Celiac Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Aug 2012
Alphatec Spine Launches New MIS Device, the BridgePoint(TM) Spinous Process Fixation System
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 31 Jul 2012
Benvenue Medical Completes Enrollment in KAST Study Evaluating Kiva(R) vs. Kyphoplasty
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 17 Jul 2012
Hologic and Gen-Probe Announce Clearance from German Federal Cartel Office for Hologic's Acquisition of Gen-Probe
Devices Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 28 Jun 2012
Benvenue Medical Secures $25 Million Series D Financing
Devices Orthopaedic Neurosurgery Venture Capital

HSMN NewsFeed - 27 Jun 2012
Kedem Pharmaceuticals to Appoint New Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 May 2012
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim(R) in the U.S.
Biopharmaceuticals Urology

HSMN NewsFeed - 1 May 2012
RF-TVA Therapy Offers Hope for Patients Suffering from Osteoporosis-Related Spine Fractures
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 30 Apr 2012
Hologic to Acquire Gen-Probe
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 21 Mar 2012
Alphatec Spine Appoints New Vice President of Operations
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 14 Mar 2012
FDA Approves BINOSTO(TM), First and Only Effervescent Osteoporosis Treatment in a Buffered Solution
Biopharmaceuticals Drug Delivery Licensing FDA

HSMN NewsFeed - 12 Mar 2012
Asahi Kasei Announces Agreement to Acquire ZOLL Medical
Devices Mergers & Acquisitions

HSMN NewsFeed - 15 Feb 2012
BioSante Pharmaceuticals Announces FDA Approval for Bio-T-Gel™
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Feb 2012
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Dec 2011
Response Genetics Names Thomas A. Bologna Chairman and CEO
Diagnostics Personnel

HSMN NewsFeed - 16 Dec 2011
Radius Closes $21.4 Million Third and Final Equity Tranche of Previously Announced Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 Dec 2011
Radius Transitions Company Leadership; Names Michael Wyzga President and Chief Executive Officer to Advance Phase 3 Osteoporosis Drug and Drive Corporate Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Nov 2011
Alphatec Spine Appoints New Senior Vice President, Global Marketing and Asia Pacific
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 10 Oct 2011
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn(R)
Biopharmaceuticals Licensing

HSMN NewsFeed - 19 Sep 2011
FDA Approves New Indications for Prolia(R) (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 13 Sep 2011
Alvine Pharmaceuticals Appoints James D. Watson as Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Aug 2011
Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jul 2011
Alphatec Spine, Inc. Receives Japanese Regulatory Shonin Approval for Illico SE(TM) Posterior Fixation Percutaneous Screw System for Minimally Invasive Surgery
Devices Neurosurgery Orthopaedic Regulatory

HSMN NewsFeed - 1 Jul 2011
Medtronic Introduces the CD HORIZON(R) Fenestrated Screw Spinal System
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 30 Jun 2011
Medtronic Announces U.S. Launch of New Inflatable Bone Tamp and Syringe System for Treatment of Vertebral Compression Fractures
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 30 Jun 2011
FDA Accepts Submission of New Drug Application for CORLUX for Cushing's Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 19 May 2011
Takeda to Acquire Nycomed
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 25 Apr 2011
Alphatec Holdings Announces Appointment of Patrick Ryan as Chief Operating Officer
Devices Neurosurgery Orthopaedic Personnel

HSMN NewsFeed - 18 Apr 2011
Ligand Names Matthew W. Foehr Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Apr 2011
Benvenue Medical Closes $35.5 Million Series C Financing
Devices Orthopaedic Neurosurgery Venture Capital

HSMN NewsFeed - 4 Apr 2011
Alphatec Spine Receives 510(k) Clearance for Its Solus(TM) Anterior Lumbar Interbody Fusion System
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 29 Mar 2011
Alphatec Spine Announces the Addition of Leslie H. Cross to Its Board of Directors
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 21 Mar 2011
Kyphon(R) Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients
Devices Orthopaedic Neurosurgery Oncology

HSMN NewsFeed - 11 Mar 2011
Orthofix Sports Medicine Launches Three New Products in March
Devices Orthopaedic

HSMN NewsFeed - 9 Mar 2011
Orthofix International Promotes Brian McCollum to Chief Financial Officer
Devices Orthopaedic Personnel

HSMN NewsFeed - 1 Mar 2011
Forest Announces FDA Approval of Daliresp(TM) (Roflumilast) as a Treatment to Reduce the Risk of COPD Exacerbations in Patients with Severe COPD Associated with Chronic Bronchitis and a History of Exacerbations
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Feb 2011
Hologic Receives FDA Approval for First 3-D Digital Mammography (Breast Tomosynthesis) System
Devices Radiology FDA

HSMN NewsFeed - 8 Feb 2011
Hologic Targets Women's Health Professionals at ECR 2011
Devices Radiology Oncology

HSMN NewsFeed - 26 Jan 2011
Ligand Acquires CyDex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 Jan 2011
Eurand Announces Agreement With Nycomed for ZENPEP(R) in Russia-CIS
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 11 Jan 2011
Orthofix International Promotes Robert S. Vaters to Chief Operating Officer
Devices Orthopaedic Personnel

HSMN NewsFeed - 10 Jan 2011
Optimer Pharmaceuticals Announces Key Additions to Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jan 2011
Hologic Acquires Interlace Medical
Devices Surgery Mergers & Acquisitions

HSMN NewsFeed - 5 Jan 2011
Teva Completes Acquisition of Théramex
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Jan 2011
Alphatec Spine, Inc. Announces the First Three-Level Guided Lumbar Interbody Fusion Procedure Performed Using the Revolutionary ARC(TM) Portal Access System
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 15 Dec 2010
Orthofix International Announces Reorganization And Settlement with NuVasive and Osiris Therapeutics
Devices Orthopaedic Neurosurgery Litigation

HSMN NewsFeed - 14 Dec 2010
Human Genome Sciences Appoints Colin Goddard, Ph.D., to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Nov 2010
Hologic Receives FDA Approvable Letter for Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System
Devices Radiology Oncology FDA

HSMN NewsFeed - 10 Nov 2010
FDA Approves Bionovo's Clinical Development Plan for Menerba
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Nov 2010
Alphatec Spine Appoints New Senior Vice President, Global Human Resources
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 2 Nov 2010
Ligand Announces Approval for Revolade(R) in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 2 Nov 2010
Unigene Names Alex Martin VP Business Development and Head of Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Nov 2010
Ortho Clinical Diagnostics Receives FDA Clearance for Intact Parathyroid Hormone Assay
Diagnostics FDA

HSMN NewsFeed - 25 Oct 2010
Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 Oct 2010
Medtronic Announces New Inflatable Bone Tamp for Treatment of Vertebral Compression Fractures
Devices FDA Orthopaedic Neurosurgery

HSMN NewsFeed - 11 Oct 2010
Alphatec Holdings Announces Appointment of Michael O'Neill, FCMA, as Chief Financial Officer
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 11 Oct 2010
Warner Chilcott Announces FDA Approval of Next Generation Actonel
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Oct 2010
Medtronic Announces New Curette for Treatment of Vertebral Compression Fractures
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 5 Oct 2010
Alphatec Spine, Inc. Releases PureGen(TM) Osteoprogenitor Cell Allograft to Facilitate Bone Regeneration and Announces First Patient Procedure Performed in the World
Devices Regenerative Medicine Orthopaedic Neurosurgery

HSMN NewsFeed - 29 Sep 2010
Osseon Treats 1,000 Patients With Osseoplasty Procedure for Vertebral Compression Fractures
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 25 Sep 2010
Hologic's Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel
Devices Radiology Oncology FDA

HSMN NewsFeed - 24 Sep 2010
ArthroCare Receives FDA Clearance for Parallax Contour Vertebral Augmentation Device
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 22 Sep 2010
Novartis Drug SOM230 is First Medical Therapy to Show Efficacy in a Phase III Trial in Cushing's Disease, a Debilitating Hormonal Disorder
Biopharmaceuticals

HSMN NewsFeed - 26 Aug 2010
CareFusion Announces National Launch of Spinal Fracture Device
Devices Interventional Orthopaedic Neurosurgery

HSMN NewsFeed - 2 Aug 2010
Aragon Pharmaceuticals Appoints Richard A. Heyman CEO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 23 Jul 2010
Emisphere Provides an Update on Osteoarthritis Phase III Study With Oral Calcitonin
Biopharmaceuticals

HSMN NewsFeed - 22 Jul 2010
Tarsa Therapeutics Advances Phase III ORACAL Trial of its Oral Calcitonin for the Treatment of Postmenopausal Osteoporosis
Biopharmaceuticals

HSMN NewsFeed - 28 Jun 2010
New High-Resolution Computer Tomography Data Demonstrates EVISTA(R)'s Effect on Bone Quality in Osteoporotic Patients
Biopharmaceuticals

HSMN NewsFeed - 22 Jun 2010
International Stem Cell Corporation Names Charles J. Casamento to Board of Directors
Regenerative Medicine Personnel

HSMN NewsFeed - 21 Jun 2010
Medtronic Launches Bone Cement with Hydroxyapatite in the United States
Devices Orthopaedic

HSMN NewsFeed - 9 Jun 2010
Unigene Appoints New CEO, Ashleigh Palmer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jun 2010
FDA Approves Amgen's Prolia(TM) (Denosumab) for Treatment of Postmenopausal Women With Osteoporosis at High Risk for Fracture
Biopharmaceuticals FDA

HSMN NewsFeed - 28 May 2010
Prolia(R) (Denosumab) Granted Marketing Authorization in the European Union
Biopharmaceuticals Regulatory

HSMN NewsFeed - 26 May 2010
Alvine Pharmaceuticals Announces Equity Investment by Abbott Biotech Ventures Inc.
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 May 2010
Roche and Biogen Idec Announce Their Decision to Discontinue the ocrelizumab Clinical Development Programme in Patients with Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 11 May 2010
Hologic Unveils Next Generation NovaSure Endometrial Ablation System
Devices

HSMN NewsFeed - 6 May 2010
Alphatec Spine Adds New Vice President and General Manager, Latin America
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 3 May 2010
FDA Approved VIMOVO(TM) for Arthritis Patients at Risk of Developing NSAID-Associated Gastric Ulcers
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 26 Apr 2010
Nycomed and Merck & Co., Inc., Announce Commercialization Agreements For Daxas(R) in Europe and Canada
Biopharmaceuticals Distribution

HSMN NewsFeed - 13 Apr 2010
MicroCHIPS Taps Medical Industry Veteran as Next CEO
Devices Personnel

HSMN NewsFeed - 6 Apr 2010
Baxter and Nycomed Announce FDA Approval of TachoSil(R)
Devices Surgery FDA

HSMN NewsFeed - 5 Apr 2010
DFine Inc Launches Next Generation Access System for RF Kyphoplasty
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 30 Mar 2010
SpineAlign Medical Announces VerteLift, New Name for Innovative System for Vertebral Compression Fracture Treatment
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 16 Mar 2010
Genentech Submits Supplemental Biologics License Application for ACTEMRA(R) (tocilizumab) for Prevention of Structural Joint Damage and Improvement of Physical Function in Rheumatoid Arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Mar 2010
Afraxis Appoints Chief Scientific Officer and Vice President, Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Mar 2010
Stryker Interventional Spine Launches VertaPlex(R) HV
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 25 Feb 2010
Alphatec Spine Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Scient'x Groupe S.A.S.
Devices Neurosurgery Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 20 Feb 2010
FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Feb 2010
Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Metastases
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Feb 2010
Alphatec Spine Receives CE Mark for its OsseoScrew(TM) Spinal Fixation System and Its GLIF/ ARC(TM) Portal Access System
Devices Orthopaedic Neurosurgery Regulatory

HSMN NewsFeed - 28 Jan 2010
Ligand Completes Acquisition of Metabasis
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 Jan 2010
Alphatec Spine, Inc. Enters Into Exclusive Distribution Agreement With Parcell Spine, LLC
Devices Neurosurgery Orthopaedic Licensing

HSMN NewsFeed - 9 Jan 2010
FDA Approves ACTEMRA(R) (tocilizumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Jan 2010
Corcept Therapeutics Announces Four Anticipated Milestones for 2010
Biopharmaceuticals

HSMN NewsFeed - 18 Dec 2009
Ligand Announces Positive Regulatory Opinion in Europe for Revolade for Chronic Immune Thrombocytopenic Purpura
Biopharmaceuticals Regulatory

HSMN NewsFeed - 17 Dec 2009
Alphatec Spine Agrees to Acquire Scient'x Groupe SAS
Devices Orthopaedic Neurosurgery Mergers & Acquisitions

HSMN NewsFeed - 16 Dec 2009
Merck Appoints Dr. Michael Rosenblatt As Executive Vice President & Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Dec 2009
Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care
Biopharmaceuticals Oncology

HSMN NewsFeed - 9 Dec 2009
Orthofix International Introduces New Line Of Walker Boots
Devices

HSMN NewsFeed - 4 Dec 2009
Orthofix International Introduces FUSION(R) Lateral OA Brace With New Low-Profile Hinge
Devices Orthopaedic

HSMN NewsFeed - 5 Nov 2009
Alphatec Spine, Inc. Enters Supply and Distribution Agreement With ETEX Corporation for Novel Biologics Products
Devices Distribution Neurosurgery Orthopaedic

HSMN NewsFeed - 27 Oct 2009
Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 19 Oct 2009
Amgen Provides Update on Status of Prolia(TM) (Denosumab) Biologics License Application (BLA) Submitted to the U.S. Food and Drug Administration (FDA)
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Sep 2009
Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
Diagnostics Regulatory

HSMN NewsFeed - 24 Sep 2009
Teva Provides Update on Generic Evista(R) Litigation
Biopharmaceuticals Generics Oncology Litigation

HSMN NewsFeed - 22 Sep 2009
Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 Sep 2009
Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Sep 2009
Alvine Pharmaceuticals Raises $21.5 Million Series A Extension
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Sep 2009
Wyeth Presents Data from Five-Year Vertebral Fracture Prevention Study with Bazedoxifene
Biopharmaceuticals

HSMN NewsFeed - 14 Sep 2009
Lilly Names New Business Leaders
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Sep 2009
Instanyl(R) (intranasal fentanyl spray) Sets New Standard in Management of Breakthrough Cancer Pain
Biopharmaceuticals

HSMN NewsFeed - 1 Sep 2009
FDA Clears Hologic's MammoSite(R) ML Radiation Therapy System for the Treatment of Early-Stage Breast Cancer
Devices Oncology FDA

HSMN NewsFeed - 24 Aug 2009
Warner Chilcott Acquires P&G's Global Pharmaceuticals Business
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 19 Aug 2009
Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
Biopharmaceuticals Onology

HSMN NewsFeed - 19 Aug 2009
Orthofix International Names Accomplished Medical Device Industry Executive to Board of Directors
Devices Orthopaedic Neurosurgery Personnedl

HSMN NewsFeed - 17 Aug 2009
Orthofix International Appoints Former Stryker Executive as President of Spinal Implants Division
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 30 Jul 2009
Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
Devices Regenerative Medicine Wound Care

HSMN NewsFeed - 27 Jul 2009
Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
Biopharmaceuticals

HSMN NewsFeed - 27 Jul 2009
Halozyme Therapeutics Appoints Jonathan Leff, M.D. as Vice President, Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jul 2009
Orthofix International Announces Development & Marketing Agreement with Stout Medical Group
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 15 Jul 2009
Orthofix International Receives CE Marking for Advent Cervical Disc
Devices Orthopaedic Neurosurgery Regulatory

HSMN NewsFeed - 7 Jul 2009
Alphatec Spine, Inc. Enters Agreement with International Spinal Innovations, LLC
Devices Neurosurgery Orthopaedic Licensing

HSMN NewsFeed - 19 Jun 2009
Alphatec Spine Reaches Milestone of OsseoFix Adoption
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 15 Jun 2009
Eli Lilly and Company Announces New Drug Discovery Initiative
Biopharmaceuticals Oncology Endocrinology

HSMN NewsFeed - 9 Jun 2009
Par Pharmaceutical Begins Shipment of Generic Miacalcin(R)
Biopharmaceuticals Generics

HSMN NewsFeed - 1 Jun 2009
FDA Approves Reclast(R) to Prevent Osteoporosis in Postmenopausal Women With Convenient Less Frequent Dosing
Biopharmaceuticals FDA

HSMN NewsFeed - 26 May 2009
Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients
Biopharmaceuticals

HSMN NewsFeed - 5 May 2009
Orthofix International Announces Limited Market Release of Trinity Evolution and Completion of First Surgical Procedure Using New Stem Cell-Based Allograft
Devices Regenerative Medicine Orthopaedic

HSMN NewsFeed - 4 May 2009
Alphatec Spine Introduces the GLIF (Guided Lateral Interbody Fusion) Technique and the ARC Portal Access System
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 27 Apr 2009
Ligand Announces Approval in Europe of CONBRIZA for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
Biopharmaceuticals Regulatory

HSMN NewsFeed - 27 Apr 2009
First Ever Prospective Fracture Study in Prostate Cancer Patients on ADT Reveals These Men Are at High Risk for Skeletal Fractures
Biopharmaceuticals Oncology Urology

HSMN NewsFeed - 22 Apr 2009
Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 21 Apr 2009
Orthofix International Announces Expanded Three-Year Supply Contract with Novation
Devices Orthopaedic Group Purchasing

HSMN NewsFeed - 15 Apr 2009
Orthofix International Announces New Agreement To Expand Distribution of Spine Implants in the U.K.
Devices Orthopaedic Neurosurgery Distribution

HSMN NewsFeed - 24 Mar 2009
FABLYN Approved in Europe for the Treatment of Osteoporosis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Mar 2009
Biodel to Submit New Drug Application for VIAject to FDA
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 19 Mar 2009
Alvine Pharmaceuticals Appoints Dr. Daniel C. Adelman, M.D. as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Mar 2009
FDA Approves Two Hologic HPV Tests
Diagnostics FDA

HSMN NewsFeed - 12 Mar 2009
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Mar 2009
Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 24 Feb 2009
Largest Study on Balloon Kyphoplasty Demonstrates Superior Benefits Compared to Non-Surgical Care in Treating Vertebral Compression Fractures
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 23 Feb 2009
Alphatec Spine Licenses New Technology to Treat Lumbar Spinal Stenosis
Devices Neurosurgery Orthopaedic Licensing

HSMN NewsFeed - 23 Feb 2009
Benvenue Medical Receives CE Mark Approval for Kiva VCF Treatment System
Devices Orthopaedic Neurosurgery Regulatory

HSMN NewsFeed - 19 Feb 2009
Small Bone Innovations Receives European Union CE Mark for Its PRECISE SD Distal Volar Radius Plating System
Devices Orthopaedic Regulatory

HSMN NewsFeed - 17 Jan 2009
Pfizer Receives FDA Complete Response Letter for Lasofoxifene
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Dec 2008
Amgen Submits Biologics License Application for FDA Approval of Denosumab in Women With Postmenopausal Osteoporosis and in Patients Undergoing Hormone Ablation for Either Prostate or Breast Cancer
Biopharmaceuticals

HSMN NewsFeed - 8 Dec 2008
First Head-To-Head Study Shows That Protelos(R) (Strontium Ranelate) Builds Better Bone Than Bisphosphonate
Biopharmaceuticals

HSMN NewsFeed - 4 Dec 2008
Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab)
Biopharmaceuticals

HSMN NewsFeed - 27 Nov 2008
Helsinn Healthcare and Zealand Pharma Sign a Partnering Agreement for ZP1846, a Novel GLP-2 Agonist
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Nov 2008
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease
Biopharmaceuticals

HSMN NewsFeed - 20 Nov 2008
Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Nov 2008
Medtronic Adds Innovative Bone Cement Delivery System to Its Spine Product Portfolio
Devices Neurosurgery Orthopaedic Acquisitions

HSMN NewsFeed - 5 Nov 2008
Akesis Pharmaceuticals Appoints Carl LeBel as CEO and Jay Lichter as Executive Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Nov 2008
DAIICHI SANKYO Acquires Merck Serono's Cardio-Metabolism Sales Force and Products in Turkey
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 31 Oct 2008
Alphatec Spine Expands European Presence; Names Peter Kohlbecher as Vice President, General Manager - Europe
Devices Neurosurgery Orthopaedic Personnel

HSMN NewsFeed - 28 Oct 2008
DFine Secures $30 Million in Series D Funding
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 27 Oct 2008
CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
Biopharmaceuticals

HSMN NewsFeed - 20 Oct 2008
Medtronic Marks World Osteoporosis Day with Milestone in Kyphon(R) Balloon Kyphoplasty Procedures
Devices Orthopaedic

HSMN NewsFeed - 15 Oct 2008
Lilly Launches New FORTEO Delivery Device
Biopharmaceuticals Devices Drug Delivery

HSMN NewsFeed - 13 Oct 2008
Orthofix International Benefits From Recent Agreements And FDA Approvals
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 7 Oct 2008
Alphatec Spine Launches New Orthobiologics Product - ProFUSE Bone Scaffold Packaged in Proprietary Vacuum Infusion Packaging System
Devices Neurosurgery Orthopaedic

HSMN NewsFeed - 2 Oct 2008
Orthofix International Receives 510(k) Approval For Next Generation Lumbar Fixation System
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 25 Sep 2008
Alphatec Spine Announces 510(k) Clearance for Its Novel Cervical Interbody Implant
Devices Neurosurgery Orthopaedic FDA

HSMN NewsFeed - 25 Sep 2008
Merck & Co., Inc. and Japan Tobacco Inc. Sign Licensing Agreement for Novel Osteoanabolic Drug Candidate to Treat Osteoporosis
Biopharmaceuticals Licensing

HSMN NewsFeed - 23 Sep 2008
Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Sep 2008
Denosumab Osteoporosis Trial Finds Patients Transitioned from Alendronate (Fosamax(R)) to Denosumab Achieved Significantly Greater Gains in Bone Mineral Density versus Those Continuing on Alendronate
Biopharmaceuticals

HSMN NewsFeed - 12 Sep 2008
Sun Pharma Gets USFDA Approval for Generic Fosamax (R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 8 Sep 2008
Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Sep 2008
Orthofix International Appoints Former Inamed Senior Executive as Chief Financial Officer
Devices Personnel

HSMN NewsFeed - 5 Sep 2008
Orthofix International Announces Expansion of Product Offerings
Devices Orthopaedic Neurosurgery FDA

HSMN NewsFeed - 5 Sep 2008
Ligand Pharmaceuticals and the SALK Institute Enter Settlement Agreement and Mutual Release of All Claims
Biopharmaceuticals Litigation

HSMN NewsFeed - 5 Sep 2008
Elan and Biogen Idec Initiate First Clinical Trial of TYSABRI(R) in Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Aug 2008
Monoclonal Antibody Sales to Almost Double in Coming Years
Biopharmaceuticals

HSMN NewsFeed - 28 Aug 2008
Orthofix International Announces Management Change in Spine Division
Devices Neurosurgery Orthopaedic Personnel

HSMN NewsFeed - 25 Jul 2008
Amgen Announces Positive Top-Line Results for Denosumab Pivotal Postmenopausal Osteoporosis Trial
Biopharmaceuticals

HSMN NewsFeed - 14 Jul 2008
Immunomedics Announces Worldwide License and Collaboration Agreement With Nycomed for Veltuzumab for Non-Cancer Indications
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 8 Jul 2008
Agile Therapeutics Appoints Senior Executive Jeffrey Frick as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2008
Orthofix International Promotes Brad Mason to Group President, North America
Devices Orthopaedic Personnel

HSMN NewsFeed - 30 Jun 2008
Akesis Pharmaceuticals Names Carl LeBel as President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jun 2008
Orthofix International Acquires Intellectual Property For Next Generation Spinal System
Devices Neurosurgery Orthopaedic Acquisitions

HSMN NewsFeed - 13 Jun 2008
ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies
Biopharmaceuticals

HSMN NewsFeed - 12 Jun 2008
Lilly and TransPharma Medical Announce Licensing and Development Agreement
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 10 Jun 2008
Orthofix International Appoints Chief Compliance and Government Affairs Officer
Devices Personnel

HSMN NewsFeed - 10 Jun 2008
Nastech Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Jun 2008
Hologic to Acquire Third Wave Technologies
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 5 Jun 2008
FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
Biopharmaceuticals FDA

HSMN NewsFeed - 28 May 2008
Denosumab Achieved Superior Bone Mineral Density Gains in Head-to-Head Trial versus Weekly Alendronate (FOSAMAX(R))
Biopharmaceuticals

HSMN NewsFeed - 27 May 2008
Odanacatib, Merck's Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 May 2008
Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
Biopharmaceuticals FDA

HSMN NewsFeed - 21 May 2008
Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50
Biopharmaceuticals

HSMN NewsFeed - 21 May 2008
Lilly Announces Changes in Key Leadership Roles
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 May 2008
Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 20 May 2008
Biodel Inc. Announces Appointment of Alan Krasner, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 May 2008
Denosumab Osteoporosis Study Meets Primary and All Secondary Bone Mineral Density Endpoints in Alendronate (FOSAMAX(R)) Transition Study
Biopharmaceuticals

HSMN NewsFeed - 14 May 2008
Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
Biopharmaceuticals Generics Regulatory

HSMN NewsFeed - 9 May 2008
Alphatec Holdings, Inc. Announces Planned Management Transition
Devices Neurosurgery Orthopaedic Personnel

HSMN NewsFeed - 7 May 2008
Alphatec Holdings, Inc. Reaches Successful Settlement and Release Agreement to License Pedicle Screw Technology
Devices Neurosurgery Orthopaedic Licensing

HSMN NewsFeed - 6 May 2008
GTx Appoints Kenneth S. Robinson, MD to the Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Apr 2008
FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Apr 2008
Lilly to Streamline Indianapolis Manufacturing and Engineering Operations
Biopharmaceuticals

HSMN NewsFeed - 14 Apr 2008
Stem Cells From Menstrual Blood Show Therapeutic Potential
Regenerative Medicine

HSMN NewsFeed - 9 Apr 2008
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in Korea
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 4 Apr 2008
Orthofix International Announces Management Change
Devices Personnel

HSMN NewsFeed - 3 Apr 2008
Alphatec Holdings, Inc. Names Veteran Executive Mitsuo Asai President of Alphatec Pacific, Inc.
Devices Neurosurgery Orthopaedic Personnel

HSMN NewsFeed - 2 Apr 2008
Pivotal Phase 3 Data Show Denosumab Increased Bone Density at Multiple Skeletal Sites in Early and Later Stage Postmenopausal Women
Biopharmaceuticals

HSMN NewsFeed - 20 Mar 2008
International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet
Biopharmaceuticals

HSMN NewsFeed - 20 Mar 2008
Medtronic Commends World Health Organization for Spinal Fracture Risk Tool
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 20 Mar 2008
Zelos Therapeutics Appoints David S. Krause, MD, FACP, as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Mar 2008
Orthofix International Announces Sale of Pain Care(R) Assets in its Sports Medicine Subsidiary
Devices

HSMN NewsFeed - 17 Mar 2008
NPS Reports Successful GATTEX(TM) Extension Study
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 10 Mar 2008
Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Mar 2008
GTx Announces Additional Top Line Phase III Data Demonstrating Toremifene Citrate 80 mg Reduced Hot Flashes in Men with Prostate Cancer on Androgen Deprivation Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Feb 2008
Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel
Biopharmaceuticals Litigation

HSMN NewsFeed - 26 Feb 2008
NPS Pharmaceuticals Announces Senior Management Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Feb 2008
Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Feb 2008
EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study
Devices Interventional Gastroenterology

HSMN NewsFeed - 25 Feb 2008
GTx's Toremifene Citrate 80 mg Meets Primary and Key Endpoints in Phase III Trial in Advanced Prostate Cancer Patients on Androgen Deprivation Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 6 Feb 2008
Barr Launches Generic Fosamax(R) Tablets, 70 mg
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 6 Feb 2008
Teva Announces Approval of Generic Fosamax(R) Tablets, 5 mg, 10 mg, 35 mg, 40 mg and 70 mg
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 28 Jan 2008
Sepracor Acquires Exclusive U.S. Rights to Nycomed's ALVESCO(R) HFA and OMNARIS(TM) AQ Products as Well as Ciclesonide Pipeline
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 28 Jan 2008
Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Jan 2008
Denosumab Osteoporosis Study Met Primary and All Secondary Bone Mineral Density Endpoints in a Head-to-Head Comparison with Weekly Alendronate (FOSAMAX(R))
Biopharmaceuticals

HSMN NewsFeed - 23 Jan 2008
The American Association of Clinical Endocrinologists (AACE) Strongly Supports the FDA in Its Concerns Regarding the Marketing and Use of So-Called Bio-Identical Hormones
Biopharmaceuticals. FDA

HSMN NewsFeed - 22 Jan 2008
Hologic Announces Sale of Gestiva(TM)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 22 Jan 2008
Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
Biopharmaceuticals

HSMN NewsFeed - 16 Jan 2008
ALVESCO(R) Gains FDA Approval for the U.S. Market
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Jan 2008
Benvenue Medical Closes $15 Million Series B Financing
Devices Neurosurgery Orthopaedic Venture Capital

HSMN NewsFeed - 7 Jan 2008
Nastech Appoints Bruce R. York as Interim Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Dec 2007
Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Dec 2007
Alphatec Holdings, Inc. Acquires an Exclusive Worldwide License for Innovative Pedicle Screw Technology
Devices Neurosurgery Orthopaedic Licensing

HSMN NewsFeed - 20 Dec 2007
Nastech Announces Promotion of Gordon Brandt, M.D. to President
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Dec 2007
Pivotal Phase 3 Data Show Denosumab Increased Bone Density Throughout Skeleton in Non-Metastatic Breast Cancer Patients on Adjuvant Aromatase Inhibitor Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Dec 2007
FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable
Devices FDA

HSMN NewsFeed - 21 Nov 2007
Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 15 Nov 2007
Zosano Pharma, Inc. Announces Funding Close Totaling $90 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 14 Nov 2007
FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals

HSMN NewsFeed - 14 Nov 2007
Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Nov 2007
Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs
Biopharmaceuticals

HSMN NewsFeed - 6 Nov 2007
Orthofix International Names Timothy M. Adams as Chief Financial Officer
Devices Personnel

HSMN NewsFeed - 1 Nov 2007
Bentley Announces Its First Product Approval in France
Biopharmaceuticals Generics Regulatory

HSMN NewsFeed - 1 Nov 2007
FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 30 Oct 2007
Nycomed Signs Definitive Agreement to Acquire Bradley Pharmaceuticals, Inc., Strengthening US Specialty Business
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 30 Oct 2007
Bradley Pharmaceuticals Announces Definitive Merger Agreement with Nycomed for $20 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Oct 2007
Bentley Announces Product Approvals in Spain and Ireland
Biopharmaceuticals Generics Regulatory

HSMN NewsFeed - 25 Oct 2007
Meda Acquires Recip
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 24 Oct 2007
MicroCHIPS Hires Industry Veteran Robert Farra to Lead Diabetes and Drug Delivery Product Programs
Devices Personnel

HSMN NewsFeed - 22 Oct 2007
Hologic and Cytyc Complete Merger
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 18 Oct 2007
Hologic Stockholders Approve Merger with Cytyc
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 16 Oct 2007
Kyphon Stockholders Approve Merger with Medtronic
Devices Mergers & Acquisitions

HSMN NewsFeed - 15 Oct 2007
Medtronic and Kyphon Announce Clearances in Spain, Austria and Cyprus for the Merger of Medtronic and Kyphon
Devices Mergers & Acquisitions

HSMN NewsFeed - 15 Oct 2007
Ligand Earns Milestone Payment as Wyeth Submits European Market Authorization for Bazedoxifene
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Oct 2007
Teva Announces Approval of Generic Actonel(R)
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 4 Oct 2007
Alvine Pharmaceuticals Announces Management Additions
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Oct 2007
Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery
Biopharmaceuticals Personnel Drug Delivery

HSMN NewsFeed - 3 Oct 2007
Orthofix International Acquires InSWing(TM) Interspinous Process Spacer
Devices Neurosurgery Orthopaedic Acquisitions

HSMN NewsFeed - 26 Sep 2007
NPS Pharmaceuticals and Nycomed Announce Licensing Agreement for GATTEX(TM) in Territories Outside North America
Biopharmaceuticals Gastroenterology Licensing

HSMN NewsFeed - 25 Sep 2007
Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
Devices Orthopaedic

HSMN NewsFeed - 21 Sep 2007
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Sep 2007
New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
Biopharmaceuticals

HSMN NewsFeed - 19 Sep 2007
Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
Biopharmaceuticals

HSMN NewsFeed - 19 Sep 2007
PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Sep 2007
Hologic Acquires Biolucent, Inc.
Devices Mergers & Acquisitions

HSMN NewsFeed - 19 Sep 2007
Medtronic and Kyphon Announce Clearance from German Federal Cartel Office for the Merger of Medtronic and Kyphon
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 18 Sep 2007
Increased Bone Mineral Density Seen in Phase IIB Study with Odanacatib, Formerly MK-0822, An Investigational Cathepsin K Inhibitor
Biopharmaceuticals

HSMN NewsFeed - 18 Sep 2007
Acceleron Pharma Appoints John L. Knopf, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Sep 2007
First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
Biopharmaceuticals

HSMN NewsFeed - 17 Sep 2007
VLST Corp Names Consuelo M. Blosch, M.D., Vice President of Clinical and Regulatory and Dan Allison, Ph.D., Sr. Director of Therapeutic Design
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Sep 2007
Federal Trade Commission Clears Kyphon's Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech
Devices Neurosurgery Orthopaedic Acquisitions

HSMN NewsFeed - 17 Sep 2007
A Major Pharmaceutical Company Has Taken an Exclusive Option To BA058, a Compound Licensed by Ipsen to Radius in 2005
Biopharmaceuticals Licensing

HSMN NewsFeed - 14 Sep 2007
FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 11 Sep 2007
Medtronic and Kyphon Announce Early Termination of Hart-Scott-Rodino Waiting Period for the Merger of Medtronic and Kyphon
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 7 Sep 2007
Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 28 Aug 2007
Indevus Announces Submission of New Drug Application
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 18 Aug 2007
Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Aug 2007
Pfizer Says Growth in Phase II Portfolio Supports Goal of Tripling Phase III Portfolio by 2009
Biopharmaceuticals

HSMN NewsFeed - 1 Aug 2007
Genta and Emisphere Technologies File IND with FDA for Oral Drug to Treat Bone Disease
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 31 Jul 2007
Endocrinologists Welcome FDA Avandia Recommendation
Biopharmaceuticals Endocrinology Cardiology FDA

HSMN NewsFeed - 27 Jul 2007
Medtronic to Acquire Kyphon for $3.9 Billion
Devices Orthopaedic Neurosurgery Mergers & Acquisitions

HSMN NewsFeed - 25 Jul 2007
Fourth ACTEMRA(TM) (tocilizumab) Phase III Study Demonstrates Significant Clinical Benefit in RA Patients
Biopharmaceuticals

HSMN NewsFeed - 24 Jul 2007
FDA Advisory Committee Recommends Approval of EVISTA for the Reduction of Risk for Invasive Breast Cancer in Two Populations of Postmenopausal Women
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 19 Jul 2007
Advanced Image Enhancement (AIE) Announces Licensing Agreement with Hologic
Devices Radiology Oncology Licensing

HSMN NewsFeed - 12 Jul 2007
GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
Biopharmaceuticals

HSMN NewsFeed - 10 Jul 2007
ACTEMRA(TM) (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 9 Jul 2007
NPS Pharmaceuticals Expands Agreement with European Partner Nycomed to Include Broader Territory Rights for Preotact(R)
Biopharmaceuticals Distribution Licensing

HSMN NewsFeed - 3 Jul 2007
Hologic and Cytyc Announce Expiration of Hart-Scott-Rodino Waiting Period
Devices Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 3 Jul 2007
Dong Wha and Procter & Gamble Pharmaceuticals Form Alliance for Osteoporosis Treatments
Biopharmaceuticals

HSMN NewsFeed - 15 Jun 2007
ACTEMRA(TM) (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
Biopharmaceuticals

HSMN NewsFeed - 13 Jun 2007
Orthofix Announces First Surgical Procedure Using Advent(TM) Cervical Disc
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 7 Jun 2007
Indevus Reports Positive Data From Phase III NEBIDO(R) Trial
Biopharmaceuticals

HSMN NewsFeed - 6 Jun 2007
Bryn Mawr Hospital is First on East Coast to Offer ``Custom Fit'' Total Knee Replacement with OtisKnee(TM)
Devices Orthopaedic

HSMN NewsFeed - 5 Jun 2007
Enzo Life Sciences, Inc., Completes Acquisition of Axxora Life Sciences, Inc.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 23 May 2007
Statement From the American Association of Clinical Endocrinologists Regarding The New England Journal of Medicine Article, "Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes"
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 22 May 2007
Enzo Biochem Individualized Oral Immune Regulation Therapy May Be Effective Approach to Treating Crohn's Disease
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 21 May 2007
Hologic and Cytyc to Merge Creating a $10 Billion Global Leader in Women's Healthcare
Devices Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 15 May 2007
Smith & Nephew and Teknimed SA Enter Into Global Distribution Agreement to Treat Compression Fractures in Spine
Devices Orthopaedic Neurosurgery Distribution

HSMN NewsFeed - 15 May 2007
Array BioPharma Appoints John Yates, MB ChB, MD, to Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 May 2007
Bill Cadwallader Joins Velcura Therapeutics, Inc. as Executive Vice President of Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 May 2007
Enzo Biochem Announces Supply and Royalty Bearing Cross-Licensing Agreements with Abbott
Diagnostics Licensing

HSMN NewsFeed - 2 May 2007
Once-yearly Reclast(R) Significantly Reduced Bone Fractures in Women with Postmenopausal Osteoporosis
Biopharmaceuticals Orthopaedic

HSMN NewsFeed - 1 May 2007
Orthofix International Strengthens Senior Management Team with Promotion of Scott Dodson to President of Orthopedics Global Business Unit
Devices Orthopaedic Personnel

HSMN NewsFeed - 30 Apr 2007
Ligand Names John P. Sharp Chief Financial Officer
Biopharmaceuticals Personne

HSMN NewsFeed - 30 Apr 2007
NicOx recruits Sanjiv Sharma as Vice President Commercial Affairs in the United States
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Apr 2007
Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Apr 2007
Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Apr 2007
Wyeth Responds to Special Report Published in New England Journal of Medicine

HSMN NewsFeed - 18 Apr 2007
Osteologix Completes Enrollment in Clinical Trial of Investigational Drug for Osteoporosis
Biopharmaceuticals

HSMN NewsFeed - 17 Apr 2007
Reclast(R) Receives US Approval as a Highly Effective Treatment for Patients with Paget's Disease of the Bone
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Apr 2007
GTx Announces Ostarine(TM) Improved Insulin Resistance among Elderly Patients in a Recently Completed Phase II Clinical Trial
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 14 Apr 2007
ARIAD files claim against Amgen and Wyeth Alleging Infringement of NF-(kappa)B Patent by Enbrel(R) and Kineret(R)
Biopharmaceuticals Litigation

HSMN NewsFeed - 10 Apr 2007
GTx, Inc. Appoints Jeff Hesselberg as Vice President of Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Apr 2007
GTx, Inc. Appoints Ronald A. Morton, Jr. MD, FACS as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Apr 2007
Osteologix Appoints Philip J. Young President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Mar 2007
Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Mar 2007
European Union CHMP Recommends Approval of First and Only Biologic Treatment for Pediatric Crohn's Disease: REMICADE(R)
Biopharmaceuticals Regulatory Gastroenterology

HSMN NewsFeed - 7 Mar 2007
U.S. Patent Board Awards Enzo Biochem Judgment in Patent Interference after Princeton University Concedes Priority
Diagnostics

HSMN NewsFeed - 2 Mar 2007
Prime Minister Tony Blair Opens Major Amgen Development Centre in London
Biopharmaceuticals

HSMN NewsFeed - 27 Feb 2007
Initiation of Phase III Program Using Emisphere's eligen(R) Technology for Oral Salmon Calcitonin
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 26 Feb 2007
Ligand Pharmaceuticals Completes Sale of AVINZA to King Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 23 Feb 2007
GTx's ACAPODENE Interim Bone Mineral Density and Lipid Data Highlighted at Press Briefing at Prostate Cancer Symposium of the American Society of Clinical Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 Feb 2007
BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Feb 2007
Orthofix Announces Introduction of New Products at Upcoming AAOS Annual Meeting
Devices Orthopaedic

HSMN NewsFeed - 2 Feb 2007
GTx's Phase III Clinical Development of ACAPODENE on Course Following Planned Safety Review
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Jan 2007
Agreement between Ipsen and MSD for the Co-Marketing in France of Adrovance(TM) for the Treatment of Postmenopausal Osteoporosis
Biopharmaceuticals Licensing

HSMN NewsFeed - 24 Jan 2007
Zylera Pharmaceuticals Announces Availability of RELAMINE for the Treatment of Osteoarthritis
Biopharmaceuticals

HSMN NewsFeed - 24 Jan 2007
Phase III ACTEMRA(TM) (tocilizumab) Study Results Demonstrate Significant Improvement in Signs and Symptoms of Patients with Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 18 Jan 2007
Kyphon Closes Acquisition of St. Francis Medical Technologies
Devices Orthopaedic Neurosurgery Mergers & Acquisitions

HSMN NewsFeed - 16 Jan 2007
Nycomed Officially Launched as Combined Group
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Jan 2007
Ligand Appoints John L. Higgins Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jan 2007
Genzyme Announces Publication of Study Showing Impact of Cerezyme on Bone Health for Patients With Type 1 Gaucher Disease
Biopharmaceuticals

HSMN NewsFeed - 15 Jan 2007
Kyphon and the Functional Anaesthetic Discography(TM) Procedure to be Featured on American Health Radio on Monday, January 15, 2007
Devices Orthopaedic

HSMN NewsFeed - 2 Jan 2007
Radius Appoints Nick Harvey Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Dec 2006
Blackstone Medical Signs New Production Agreement With Regeneration Technologies, Inc.
Devices Regenerative Medicine Orthopaedic

HSMN NewsFeed - 21 Dec 2006
Regeneration Technologies Announces Manufacturing Agreement with Blackstone Medical for BioCleanse(R)-Sterilized Spinal Allografts
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 21 Dec 2006
Kyphon Signs Definitive Agreements to Acquire All Spine-Related Assets of Disc-O-Tech Medical Technologies
Devices Orthopaedic Neurosurgery Mergers & Acquisitions

HSMN NewsFeed - 12 Dec 2006
Merck Remains Confident in Future Growth as it Executes on New Strategy
Biopharmaceuticals

HSMN NewsFeed - 8 Dec 2006
GTx Announces That Ostarine Achieved Primary Endpoint of Lean Body Mass and a Secondary Endpoint of Improved Functional Performance in a Phase II Clinical Trial and Reacquisition of Full Rights to GTx SARM Program
Biopharmaceuticals

HSMN NewsFeed - 7 Dec 2006
Eli Lilly and Company Submits New Drug Application for EVISTA for Reduction of Invasive Breast Cancer Risk in Postmenopausal Women
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Dec 2006
Nastech Pharmaceutical Company Inc. Provides Update on Parathyroid Hormone (PTH1-34) Nasal Spray for Treatment of Osteoporosis
Biopharmaceuticals

HSMN NewsFeed - 4 Dec 2006
Kyphon Signs Definitive Agreement to Acquire St. Francis Medical Technologies
Devices Neurosurgery Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 30 Nov 2006
U.S. Court of Appeals Allows Enzo Biochem Patent Infringement Suit to Proceed
Diagnostics Litigation

HSMN NewsFeed - 13 Nov 2006
New Study Shows ACTEMRA(TM) (tocilizumab) Significantly Improves Remission Rates in Patients with Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 6 Nov 2006
Raptor Pharmaceuticals Corp. Announces an Exclusive Worldwide License Agreement for Mesd Reagents for Treatment of Cancer and Osteoporosis
Biopharmaceuticals Licensing

HSMN NewsFeed - 2 Nov 2006
Osteologix Granted European Patent for Treating Cartilage and Bone Conditions
Biopharmaceuticals

HSMN NewsFeed - 25 Oct 2006
Ligand Completes Sale of Oncology Product Lines
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 24 Oct 2006
Cyclacel Pharmaceuticals Names John Womelsdorf, Ph.D., Vice President, Business Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Oct 2006
Orthofix Names New President of International Division
Devices Personnel

HSMN NewsFeed - 16 Oct 2006
Enzo Biochem Appoints Gary C. Cupit, Former Novartis Pharmaceutical Executive, President of Enzo Therapeutics Unit
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Oct 2006
Osta Announces Promising Clinical Results on Blood Tests for Parkinson's Disease & Alzheimer's Disease
Diagnostics Neurology

HSMN NewsFeed - 10 Oct 2006
Hologic to Showcase the Latest in Women's Imaging & Skeletal Health Innovations at the Largest Medical Show in the World - RSNA'06
Devices Radiology

HSMN NewsFeed - 1 Oct 2006
Jason M. Aryeh Elected to Ligand Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Sep 2006
Sciele Pharma Introduces OSTIVA(TM), a New Women's Health Product
Biopharmaceuticals

HSMN NewsFeed - 27 Sep 2006
Orthofix Announces Partnership with Texas Scottish Rite Hospital for Children
Devices Orthopaedic

HSMN NewsFeed - 26 Sep 2006
Kyphon to Showcase Continued Product Innovation at 21st Annual Meeting of North American Spine Society
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 26 Sep 2006
Medtronic to Aid Treatment of Older Adults Through Aging Spine Care Program
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 26 Sep 2006
Government Approves Lilly's Medicare Part D Patient Assistance Program
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Sep 2006
Orthofix Completes Acquisition of Blackstone Medical
Devices Orthopaedic Neurosurgery Mergers & Acquisitions

HSMN NewsFeed - 22 Sep 2006
Blackstone Medical, Inc. Advances Spine Treatment with New Product Launches at NASS '06
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 19 Sep 2006
Higher Persistency Rates Seen with FOSAMAX(R) Once Weekly Therapies Compared to Other Weekly and Monthly Oral Bisphosphonates, According to Two New Outcomes Studies
Biopharmaceuticals

HSMN NewsFeed - 18 Sep 2006
Kyphon Expands Executive Management Team
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 17 Sep 2006
Women More Likely to Stay on Once-Monthly Boniva(R) Versus Once-Weekly Osteoporosis Medicines
Biopharmaceuticals

HSMN NewsFeed - 16 Sep 2006
Once-Yearly Reclast(R)* Demonstrates Highly Significant Fracture Risk Reductions in the Treatment of Postmenopausal Osteoporosis, New Study Shows
Biopharmaceuticals

HSMN NewsFeed - 14 Sep 2006
Zimmer Holdings to Launch Innovative Locking Plate System at Orthopaedic Trauma Association Meeting
Devices Orthopaedic

HSMN NewsFeed - 13 Sep 2006
The Children's Hospital of Philadelphia Opens the Center for Celiac Disease
Gastroenterology Hospitals & Healthcare Systems

HSMN NewsFeed - 13 Sep 2006
Bristol-Myers Squibb Company and Medivir AB Announce Worldwide Collaboration to Develop and Commercialize MIV-170 for the Treatment of HIV-1 Infection in Adults
Biopharmaceuticals HIV/AIDS Licensing

HSMN NewsFeed - 12 Sep 2006
Chugai Announces Co-Development and Co-Marketing Agreement with Taisho Pharmaceutical for the Antiresorptive Bisphosphonate R484
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Jul 2006
Kyphon Appoints Frank M. Phillips, M.D. to Board of Directors
Devices Personnel

HSMN NewsFeed - 17 Jul 2006
George W. Dunbar Joins Aastrom Biosciences as Chief Executive Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 13 Jul 2006
Hologic Acquires R2 Technology, Inc.
Devices Radiology Oncology Mergers & Acquisitions

HSMN NewsFeed - 13 Jul 2006
Nastech Pharmaceutical Company Receives FDA Communication Concerning Calcitonin-Salmon Nasal Spray
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 7 Jul 2006
Hologic Signs Consent Agreement with the Federal Trade Commission Regarding Prone Bed Breast Biopsy System Intellectual Property Acquired from Fischer Imaging Corporation
Devices Oncology Mergers & Acquisitions

HSMN NewsFeed - 6 Jul 2006
Medivir: Lipsovir(R) Has Entered Phase III Clinical Study
Biopharmaceuticals

HSMN NewsFeed - 5 Jul 2006
Geron Presents New Data That Document Progress in Development of Therapeutic Products from Human Embryonic Stem Cells
Biopharmaceuticals Regenerative Medicine

HSMN NewsFeed - 29 Jun 2006
Nuvelo Expands Depth in Manufacturing and Development With Key Additions to Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jun 2006
Wyeth Submits Two New Drug Applications for Women's Health Therapies
Biopharmaceuticals

HSMN NewsFeed - 26 Jun 2006
Nastech Pharmaceutical Company Inc. Enters into Development and License Agreement With Amylin Pharmaceuticals, Inc.
Biopharmaceuticals Licensing

HSMN NewsFeed - 22 Jun 2006
In a Phase III Lipid Interim Analysis, ACAPODENE Treatment Lowered Cholesterol and Raised HDL In Prostate Cancer Patients On Androgen Deprivation Therapy
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 May 2006
Osteologix, Inc. Completes Reverse Merger Wednesday, May 24, 2006
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 24 May 2006
Hologic Receives From Federal Trade Commission HSR Second Request for Acquisition of Suros Surgical Systems
Devices Surgery Mergers & Acquisitions

HSMN NewsFeed - 10 May 2006
Unigene Enters into Exclusive Distribution Agreement for Fortical(R) Nasal Spray in Israel
Biopharmaceuticals Drug Delivery Distribution

HSMN NewsFeed - 8 May 2006
Wyeth Comments on New Report From The Nurses' Health Study Published Today in the Archives of Internal Medicine
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 May 2006
Hologic Receives FDA Clearance to Use Discovery DXA System for Detecting Cardiovascular Disease
Diagnostics Radiology Cardiology FDA

HSMN NewsFeed - 4 May 2006
Jury Rules in Favor of ARIAD and Co-Plaintiffs in Lilly NF-(kappa)B Patent Infringement Lawsuit
Biopharmaceuticals Litigation

HSMN NewsFeed - 4 May 2006
PBI Technology, Inc. Signs License Agreement for SalivaSac(R) with Evergreen Innovation Partners
Devices Diagnostics Licensing

Return to NewsFeed

Additional items found! 450

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 450 additional stories matching:
osteoporosis
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.